Advertisement

Topics

Luminex Company Profile

00:01 EDT 20th June 2018 | BioPortfolio

Luminex Corporation was incorporated in May 1995 and began commercial production of our first generation system in 1997. Luminex® (NASDAQ: LMNX) develops, manufactures and markets innovative biological testing technologies with applications throughout the life-sciences industry. The company’s open-architecture xMAP® technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately.Systems using xMAP technology (formerly known as LabMAP®) perform discrete bioassays on the surface of color-coded beads known as microspheres, which are then read in a compact analyzer. Using lasers and high-speed digital-signal processors, the analyzer simultaneously identifies the bioassay and measures the results, all in real time.

Location

12212 Technology Blvd
Austin
Texas
78727
United States of America

Contact

Phone: 512.219.8020 or 888.219.8020
Fax: 512.219.5195
Email: info@luminexcorp.com


News Articles [17 Associated News Articles listed on BioPortfolio]

BioRad Bio Plex Luminex 100 Luminex XYP Array System

$0.99 (0 Bids)End Date: Saturday Apr-14-2018 18:19:09 PDTBid now | Add to watch list Biotech365 : BioRad Bio Plex Luminex 100 Luminex XYP Array System BioMarketplace You want to propose your prod...

Bio-Rad Luminex 100 XYP SD Multiplexing Analyzer Sheath Delivery System

EUR 563.18End Date: Thursday Jun-7-2018 23:18:56 ISTBuy It Now for only: EUR 563.18Buy It Now | Add to watch list Biotech365 : Bio-Rad Luminex 100 XYP SD Multiplexing Analyzer Sheath Delivery Sys...

Luminex starts clinical trials for VERIGENE II gastrointestinal assay

Luminex has started clinical studies for the gastrointestinal (GI) assay on the VERIGENE II system.

Luminex’s Tadd Lazarus Joins Clinical Genomics as Chief Medical Officer

Tadd Lazarus has joined cancer tests company Clinical Genomics as chief medical officer. Before coming to the Bridgewater, NJ-based company, Lazarus was senior vice president and chief medical officer...

Luminex (LMNX) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow

Luminex Corporation's (LMNX) CEO Homi Shamir on Q1 2018 Results - Earnings Call Transcript

Luminex Corporation (LMNX) CEO Homi Shamir on Q4 2017 Results - Earnings Call Transcript

Luminex Announces Preliminary Revenue for the Fourth Quarter and Full Year 2017; Company to ...

Total MDx revenue of approximately $44 million, grew 12% over the fourth quarter of 2016 The MDx sample to answer portfolio generated $13 million Read more...

Drugs and Medications [0 Results]

None

PubMed Articles [17 Associated PubMed Articles listed on BioPortfolio]

The good, the bad and the ugly of luminex donor specific cross match.

The presence of donor specific antibodies directed against human leukocyte antigen significantly influences renal transplant due to antibody mediated rejection (AMR). We performed the screening of pre...

Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.

We used the Luminex Bead Array Multiplex Immunoassay to measure cytokines, chemokines and growth factors responses to the same antigens used for RD1-based Interferon γ Release Assay (IGRA) test. Seve...

Enterovirus detection in patients with acute gastroenteritis in Switzerland.

Acute gastroenteritis (GE) has a major impact on morbidity and mortality worldwide, yet comprehensive data regarding infectious agents including enteroviruses are scarce. We hypothesized that enterovi...

The impact of flow PRA on outcome in pediatric heart recipients in modern era: An analysis of the Pediatric Heart Transplant Study database.

Data from patients in the Pediatric Heart Transplant Study (PHTS) registry transplanted between 2010 and 2014 were analyzed to determine the association between HLA antibody (PRA) determined by SPA us...

Effects of Quercetin, Kaempferol, and Exogenous Glutathione on Phospho- and Total-AKT in 3T3-L1 Preadipocytes.

Obesity has been reported to be a risk factor for some types of cancer, such as prostate and lung. The AKT or PI3K-AKT is a signal transduction pathway that promotes survival and growth in response to...

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

Cytokine Evaluation of Accelerated Tooth Movement

Gingival Crevicular Fluid samples will be collected using periopapers after accelerated tooth movement technique, results will be achieve with cytokine measurements that will be done using...

Fluency Stent-Graft Versus Luminex Stent for Angioplasty of Recurrent Stenosis of the Cephalic Arch in Autogenous Arteriovenous (AV) Access for Hemodialysis

The type of hemodialysis access and preservation of this access greatly influences the quality of life and survival of patients undergoing hemodialysis. The Kidney Disease Outcomes Quality...

Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects

This is a phase i randomized, double blind clinical trial designed to evaluate the safety, tolerability and immunogenicity of the ID93 recombinant protein antigen alone or formulated with ...

ZRx-101 (NK-92) for the Treatment of Refractory or Relapsed Acute Myeloid Leukemia

The ZRx-101 cells have features similar to activated NK cells, but mediate superior anti-tumor activity against hematologic and solid tumor targets in vitro and in vivo. The utilization of...

An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects

This is a China registration study. A randomized, double-blind, placebo-controlled immunogenicity and safety study in Chinese female subjects aged 9 to 45 years and male subjects aged 9 to...

Companies [4 Associated Companies listed on BioPortfolio]

Luminex

Luminex Corporation was incorporated in May 1995 and began commercial production of our first generation system in 1997. Luminex® (NASDAQ: LMNX) develops, manufactures and markets innovative biologic...

Luminex Corp.

Luminex Corporation

One Lambda Inc.

One Lambda Inc. is a world leader in the manufacture of HLA medical diagnostic products based in Canoga Park, California. The company is committed to develop products that improve...

More Information about "Luminex" on BioPortfolio

We have published hundreds of Luminex news stories on BioPortfolio along with dozens of Luminex Clinical Trials and PubMed Articles about Luminex for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Luminex Companies in our database. You can also find out about relevant Luminex Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record